← Back
$TERN All transactions

Terns Pharmaceuticals, Inc.

▲ BUY
8 / 10

Conviction

$ Value

$20K

Shares

5,000

Price

$4

Filed

Jun 30

Why this score? (8/10)
  • Open market buy (+3)
  • % of holdings >= 20% (+2)
  • C-suite insider (+2)
  • Not a 10b5-1 plan (+1)

Insider

Name

Gengos Andrew

Title

Chief Financial Officer

CIK

0001563623

Roles

Officer

Transaction Details

Transaction Date

2025-06-27

Code

P

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

25,000

Filing Info

Accession No.

0001562180-25-005120

Form Type

4

Issuer CIK

0001831363

Gengos Andrew's History

Date Ticker Type Value
2026-01-14 TERN A $0
2026-01-14 TERN A $0
2025-10-08 TTRX A $0
2025-06-27 TERN $20K
2025-06-27 TERN $20K
2025-06-16 TERN $20K
2025-06-13 TERN $19K
2025-06-13 TERN $19K

Other Insiders at TERN (90d)

Insider Bought Sold Last
FELLOWS DAVID A 2026-02-01
KINDLER JEFFREY B 2026-02-01
Turner Heather D 2026-02-01
Azelby Robert 2026-02-01
Tripuraneni Radhika 2026-02-01
Quigley Jill M. 2026-02-01
Burroughs Amy L.
Chief Executive Officer
$572K 2026-02-17
Kuriakose Emil
Chief Medical Officer
$50K 2026-04-01